Akorn Inc (AKRX) 29.03 $AKRX Technical Analysis on Drugs

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Akorn Inc (AKRX) 29.03 $AKRX

Technical Analysis on Drugs - Generic Equities -- Akorn, Ironwood Pharma, Catalyst Pharma, and Pacira Pharma
PR Newswire - Fri Jun 10, 7:00AM CDT
On Thursday, June 09, 2016, the NASDAQ Composite ended the trading session at 4,958.62, down 0.32%; the Dow Jones Industrial Average edged 0.11% lower to finish at 17,985.19; and the S&P 500 closed at 2,115.48, down 0.17%. ActiveWallSt.com has initiated coverage on the following equities: Akorn Inc. (NASDAQ: AKRX), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX), and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX). Learn more about these stocks by accessing their free trade alerts at:
IRWD: 12.86 (+0.22), CPRX: 0.88 (-0.01), AKRX: 29.03 (+0.29), PCRX: 38.55 (+0.62)

Akorn Updates Form S-8 Status by Filing Form 10-Q's for First, Second and Third Quarters of 2015
GlobeNewswire - Thu Jun 02, 5:30AM CDT
Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it has filed quarterly reports on Forms 10-Q with the Securities and Exchange Commission (SEC) for the quarters ended March 31, 2015, June 30, 2015 and September 30, 2015. The quarterly financial results that are included in the individual Forms 10-Q were previously filed by the Company in its comprehensive Form 10-K for the fiscal year 2015 that was filed with the SEC on May 10, 2016. The individual Forms 10-Q were filed solely in order to make effective the Company's Registration Statement on Form S-8, on which the Company's securities offered under its employee benefit plan are registered.
AKRX: 29.03 (+0.29)

Akorn to Present at Two Upcoming Investor Conferences
GlobeNewswire - Tue May 31, 7:30AM CDT
Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that management will be presenting at the Jefferies 2016 Healthcare Conference and William Blair 36th Annual Growth Stock Conference in June.
AKRX: 29.03 (+0.29)

SmarTrend Watching for Potential Rebound in Shares of Akorn After 2.24% Loss
Comtex SmarTrend(R) - Thu May 26, 2:05PM CDT
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $29.37 to a high of $30.51. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $30.27 on volume of 1.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 29.03 (+0.29)

Akorn (AKRX) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Thu May 19, 7:54AM CDT
As of late, it has definitely been a great time to be an investor in Akorn, Inc. (AKRX)
AKRX: 29.03 (+0.29)

Watch for Akorn to Potentially Pullback After Gaining 7.19% Yesterday
Comtex SmarTrend(R) - Tue May 17, 1:24PM CDT
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $27.90 to a high of $30.39. Yesterday, the shares gained 7.2%, which took the trading range above the 3-day high of $28.19 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 29.03 (+0.29)

Akorn meets 1Q profit forecasts
Automated Insights - Mon May 16, 4:03PM CDT
LAKE FOREST, Ill. (AP) _ Akorn Inc. (AKRX) on Monday reported first-quarter earnings of $41.9 million.
AKRX: 29.03 (+0.29)

SmarTrend Watching for Potential Pullback in Shares of Akorn After 14.34% Gain
Comtex SmarTrend(R) - Tue May 10, 3:26PM CDT
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $24.43 to a high of $26.81. Yesterday, the shares gained 14.3%, which took the trading range above the 3-day high of $24.43 on volume of 2.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 29.03 (+0.29)

Teva's (TEVA) Stock Gains on Q1 Earnings & Revenue Beat
Arpita Dutt - Zacks Investment Research - Tue May 10, 6:18AM CDT
2016 is a transition year for Teva (TEVA) as it works on the integration of Actavis Generics and progresses with its branded pipeline.
AKRX: 29.03 (+0.29), TEVA: 51.18 (-0.01), AMPH: 15.92 (+0.33), NVS: 80.09 (+0.38)

Relypsa Soars 67% in Thursday Trading on Buyout Rumors
Arpita Dutt - Zacks Investment Research - Fri Apr 08, 8:50AM CDT
Relypsa (RLYP) shoots up on rumors that the company will be acquired.
AKRX: 29.03 (+0.29), RLYP: 17.09 (-0.08), AZN: 28.98 (+0.28), AMPH: 15.92 (+0.33)

3 Value Stocks Near 52-Week Lows Worth Buying
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 24, 8:21AM CDT
Image source: Pixabay. While many companies' shares are rising past their fair values now, others are trading at potentially bargain prices. The difficulty with bargain shopping, though, is that you may be understandably hesitant to buy stocks...
AKRX: 29.03 (+0.29), AMCX: 58.63 (+0.14), ICE: 254.94 (+2.94)

3 Beaten-Up Healthcare Stocks: Are They Bargains?
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 22, 9:26PM CDT
SOURCE: FLICKR USER ELLIOTT BROWN. A sharp sell-off in healthcare stocks has left many investors licking their wounds, but other investors might be licking their chops. With many healthcare stocks trading at their lowest valuation in years, the...
JNJ: 116.93 (+0.47), VRX: 21.56 (-0.08), AKRX: 29.03 (+0.29), DEPO: 19.30 (+0.18)

Transocean and Royal Caribbean slump, Wynn and Staples rise
AP - Tue Mar 22, 3:53PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq stock market:
SPLS: 8.88 (+0.19), ESRX: 76.33 (+0.74), RCL: 77.03 (+0.91), RIG: 11.59 (+0.19), AKRX: 29.03 (+0.29), WYNN: 102.15 (+1.43), ODP: 3.49 (+0.01), MFRM: 34.40 (+0.05), MS: 26.91 (+0.52)

Why Akorn, Inc. Is Soaring 39% Today
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 22, 12:33PM CDT
Image source: Akorn, Inc. What: Following the release of its preliminary fourth-quarter and full-year financials, shares in Akorn  (NASDAQ: AKRX) are rallying 39.05% at 1:00 p.m. Tuesday.  So what: The mid-sized generic pharmaceutical...
AKRX: 29.03 (+0.29)

Look for Shares of Akorn to Potentially Pullback after Yesterday's 36.93% Rise
Comtex SmarTrend(R) - Tue Mar 22, 11:59AM CDT
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $21.78 to a high of $26.26. Yesterday, the shares gained 36.9%, which took the trading range above the 3-day high of $21.23 on volume of 8.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 29.03 (+0.29)

Akorn Receives Expected Additional Delinquency Notice From Nasdaq
GlobeNewswire - Mon Mar 07, 6:00AM CST
Akorn, Inc. (Nasdaq:AKRX) today announced that, as expected, it has received a notice from the Nasdaq Listing Qualifications Staff stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because the Company did not timely file its Form 10-K for the year ended December 31, 2015 with the Securities and Exchange Commission (SEC) by February 29, 2016.
AKRX: 29.03 (+0.29)

Akorn Has Returned 20.2% Since SmarTrend Recommendation (AKRX)
Comtex SmarTrend(R) - Fri Feb 05, 10:52AM CST
SmarTrend identified a Downtrend for Akorn (NASDAQ:AKRX) on January 12th, 2016 at $31.33. In approximately 3 weeks, Akorn has returned 20.20% as of today's recent price of $25.00.
AKRX: 29.03 (+0.29)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 438

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 325

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 365

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 280

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 210

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 261

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 443

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 448

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 349

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading

Top 5 Most Recently Viewed Articles

ANSI Electric Vehicles Standards Panel Releases New Report

Updated Category News Views 285

ANSI Electric Vehicles Standards Panel Releases New Report In a significant step towards enhancing the adoption of electric vehicles (EVs) and their infrastructure, the American National Standards Institute (ANSI) has unveiled the May 2025 Gaps Progress Report. This report is integral to understanding the collaborative efforts being made by various stakeholders to bridge...

Continue Reading
Oklahoma Startups Thrive in Catalyst Accelerator Boot Camp

Updated Category News Views 575

Catalyst Accelerator Empowers Startups through Innovative Boot Camp The Catalyst Accelerator is thrilled to unveil a significant opportunity for six emerging tech startups in Oklahoma. This new initiative, the Government Business Boot Camp, is fashioned to equip these talented companies with the insights and tools necessary to succeed in government contracting. In...

Continue Reading
Legal Action Commences for Biogen Inc. (NASDAQ: BIIB) Investors

Updated Category News Views 200

Legal Investigation for Biogen Inc. Stockholders Bragar Eagel & Squire, P.C., a reputable law firm, is currently investigating claims against Biogen Inc. (NASDAQ: BIIB) on behalf of long-term stockholders. This investigation follows the recent filing of a class action complaint aimed at holding the company accountable for alleged misleading statements regarding its...

Continue Reading
Understanding the Urgent Need for Data Governance in AI

Updated Category News Views 133

The Growing Importance of Data Governance in AI As the landscape of business evolves, the adoption of artificial intelligence (AI) in enterprises has surged, leading to significant transformations in operations, development, and knowledge work. However, this rapid integration of AI solutions has brought about new data risks that traditional technologies often overlook....

Continue Reading
Oracle's High Debt Levels Raise Concerns for Investors

Updated Category News Views 797

Oracle’s Debt Concerns Illuminate Financial Landscape In a recent analysis, a leading strategist from J.P. Morgan has drawn attention to the substantial debt levels of Oracle Corp. (NYSE: ORCL). Reporting a staggering 500% debt-to-equity ratio, Oracle’s financial commitments appear considerably higher when compared to other companies in the sector. Analysis from J.P....

Continue Reading